Chronic Lymphocytic Leukaemia (CLL) Clinical Trial
Official title:
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma
The purpose of this study is to document the pharmacological treatment strategies used in treatment naïve and previously treated relapsed/refractory iNHL/CLL patients in the Middle East and North African (MENA) region. This study will also record encountered tumor subtype and stage and the instituted pharmacological treatments, as well as assess the clinical outcomes of treatments.
Patients will be followed up to 30 months. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02920697 -
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
|
Phase 1 | |
| Completed |
NCT01279252 -
CLL Empirical Antibiotic Regimen
|
Phase 2 | |
| Recruiting |
NCT05645172 -
Retention Rate of Acalabrutinib in a Non-interventional Setting
|